Last Tuesday seven U.S. medical centers announced that a federal grant will help them build the first collaborative electronic database for HIV/AIDS treatment results in hopes of determining the effectiveness of therapies and treatments for HIV-positive people, The New York Times reported.
The database project will be based at the University of Alabama at Birmingham and will be linked to Harvard University; Johns Hopkins University; University of Washington; University of California, San Diego; University of California, San Francisco; and Case Western Reserve University.
Through the program HIV-positive people will be asked to answer questions about symptoms, medication adherence, and other topics. Physicians will validate the information by asking participants about their answers and collecting blood samples. The project will keep confidential the identities of the 15,000 HIV-positive people in the program, the Times reports.
Each institution already has HIV/AIDS databases with the results of clinical trials for new treatments, and this project will link all of the databases together to help doctors and researchers compare the effectiveness of commonly used treatments with the clinical trial results for new treatments. (The Advocate)
These comments are reproduced as written by visitors to this Web site. They have not been edited for content, grammar, or spelling. The viewpoints appearing here are those of the writer, and do not necessarily reflect the opinion or views of advocate.com, The Advocate, or its affiliates.
Be the first to comment on this story.
If you would like to submit a comment for posting, please fill out the form above.
All comments submitted via this form are subject to posting or publication. (To send a private letter to an Advocate editor or writer, please use the e-mail button at the top of the page, or use snail mail.) If you would like your comment considered for publication in The Advocate magazine, please include your full name, your city of residence, and a phone number where you can be reached during business hours so that we can confirm your identity. Your e-mail address and telephone number are strictly confidential and will not be shared or used for any purpose other than to contact you about your comment.
See the Contact page for sending comments for reasons other than responding to Advocate editorial and news stories.
Please note that comments sent by fax or snail mail are unlikely to be posted, although they will be considered for publication along with all letters received via e-mail or via this Web page. Comments that chiefly concern Advocate.com content will be considered for posting only on the Web site. The Advocate reserves the right to edit submitted comments for grammar, spelling, obscenities, or libel; we will, however, do our best to preserve the original comment's style and intent. Comments considered for publication in The Advocate magazine may also be edited for length.